These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 23216791
21. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, Koizumi M, Tulachan SS, Ito D, Kami K, Mori T, Kawaguchi Y, Fujimoto K, Hosotani R, Imamura M. Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4125-33. PubMed ID: 15217949 [Abstract] [Full Text] [Related]
22. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer. Choi Y, Lee HJ, Jang MH, Gwak JM, Lee KS, Kim EJ, Kim HJ, Lee HE, Park SY. Hum Pathol; 2013 Nov 15; 44(11):2581-9. PubMed ID: 24055090 [Abstract] [Full Text] [Related]
24. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers. Adam AP, Sharenko AL, Pumiglia K, Vincent PA. J Biol Chem; 2010 Mar 05; 285(10):7045-55. PubMed ID: 20048167 [Abstract] [Full Text] [Related]
25. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells. Castillo LF, Tascón R, Lago Huvelle MR, Novack G, Llorens MC, Dos Santos AF, Shortrede J, Cabanillas AM, Bal de Kier Joffé E, Labriola L, Peters MG. Oncotarget; 2016 Sep 13; 7(37):60133-60154. PubMed ID: 27507057 [Abstract] [Full Text] [Related]
26. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway. Douchi D, Ohtsuka H, Ariake K, Masuda K, Kawasaki S, Kawaguchi K, Fukase K, Oikawa M, Motoi F, Naitoh T, Katayose Y, Egawa S, Unno M. Cancer Lett; 2015 Aug 28; 365(1):132-40. PubMed ID: 26047573 [Abstract] [Full Text] [Related]
27. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells. Tang NN, Zhu H, Zhang HJ, Zhang WF, Jin HL, Wang L, Wang P, He GJ, Hao B, Shi RH. World J Gastroenterol; 2014 Dec 21; 20(47):17894-904. PubMed ID: 25548487 [Abstract] [Full Text] [Related]
28. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. Nottebaum AF, Cagna G, Winderlich M, Gamp AC, Linnepe R, Polaschegg C, Filippova K, Lyck R, Engelhardt B, Kamenyeva O, Bixel MG, Butz S, Vestweber D. J Exp Med; 2008 Nov 24; 205(12):2929-45. PubMed ID: 19015309 [Abstract] [Full Text] [Related]
29. Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s). Scribner KC, Behbod F, Porter WW. Oncogene; 2013 May 23; 32(21):2631-9. PubMed ID: 22777354 [Abstract] [Full Text] [Related]
30. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Zhang H, Stephens LC, Kumar R. Clin Cancer Res; 2006 Mar 01; 12(5):1479-86. PubMed ID: 16533771 [Abstract] [Full Text] [Related]
31. An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells. Li S, Jiao J, Lu Z, Zhang M. Oncol Rep; 2009 May 01; 21(5):1223-33. PubMed ID: 19360298 [Abstract] [Full Text] [Related]
32. VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers. Bartolomé RA, Torres S, Isern de Val S, Escudero-Paniagua B, Calviño E, Teixidó J, Casal JI. Oncotarget; 2017 Jan 03; 8(1):215-227. PubMed ID: 27966446 [Abstract] [Full Text] [Related]
33. MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1. Qiao B, He BX, Cai JH, Tao Q, King-Yin Lam A. Sci Rep; 2017 Apr 20; 7():44688. PubMed ID: 28425477 [Abstract] [Full Text] [Related]
34. The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer. Fei F, Zhang D, Yang Z, Wang S, Wang X, Wu Z, Wu Q, Zhang S. J Exp Clin Cancer Res; 2015 Dec 24; 34():158. PubMed ID: 26702618 [Abstract] [Full Text] [Related]
35. The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression. Olson A, Le V, Aldahl J, Yu EJ, Hooker E, He Y, Lee DH, Kim WK, Cardiff RD, Geradts J, Sun Z. PLoS Genet; 2019 Oct 24; 15(10):e1008451. PubMed ID: 31658259 [Abstract] [Full Text] [Related]
36. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA. Nat Cell Biol; 2010 Mar 24; 12(3):247-56. PubMed ID: 20173740 [Abstract] [Full Text] [Related]
37. Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer. Park SY, Lee SJ, Cho HJ, Kim TW, Kim JT, Kim JW, Lee CH, Kim BY, Yeom YI, Lim JS, Lee Y, Lee HG. Oncotarget; 2016 Feb 23; 7(8):9501-12. PubMed ID: 26824987 [Abstract] [Full Text] [Related]
38. VE-cadherin expression and clustering maintain low levels of survivin in endothelial cells. Iurlaro M, Demontis F, Corada M, Zanetta L, Drake C, Gariboldi M, Peiro S, Cano A, Navarro P, Cattelino A, Tognin S, Marchisio PC, Dejana E. Am J Pathol; 2004 Jul 23; 165(1):181-9. PubMed ID: 15215174 [Abstract] [Full Text] [Related]
39. The VE-Cadherin/β-catenin signalling axis regulates immune cell infiltration into tumours. Zhao Y, Li J, Ting KK, Chen J, Coleman P, Liu K, Wan L, Moller T, Vadas MA, Gamble JR. Cancer Lett; 2021 Jan 01; 496():1-15. PubMed ID: 32991950 [Abstract] [Full Text] [Related]